Cargando…
Meta-analysis of the effectiveness and safety of Shenyankangfu tablets combined with losartan potassium in the treatment of chronic glomerulonephritis
OBJECTIVE: To conduct a systematic review of the efficacy and safety of Shenyankangfu tablets in combination with losartan potassium in the treatment of chronic glomerulonephritis. METHOD: We searched PubMed, Embase, Cochrane Library, CNKI, WanFang Data, and WeiPu for comparative studies on Shenyank...
Autores principales: | Feng, Pan-Feng, Chen, Xiang-Fan, Sheng, Nan, Zhu, Long-Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550056/ https://www.ncbi.nlm.nih.gov/pubmed/36215266 http://dx.doi.org/10.1371/journal.pone.0275735 |
Ejemplares similares
-
Efficacy and safety of Shenyankangfu tablets for primary glomerulonephritis: study protocol for a randomized controlled trial
por: Kou, Jia, et al.
Publicado: (2014) -
Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation
por: Jin, Meiling, et al.
Publicado: (2021) -
Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression
por: Luo, Qiuhua, et al.
Publicado: (2022) -
A Method for Content Uniformity Determination of Atenolol and Losartan Potassium in Combined Tablet Dosage Form
por: Shah, S. A., et al.
Publicado: (2010) -
Spectrophotometric method for simultaneous estimation of atenolol in combination with losartan potassium and hydrochlorothiazide in bulk and tablet formulation
por: Bari, Sanjay, et al.
Publicado: (2010)